Skip to main content

Posts

Showing posts from November, 2019

Embolic Protection Devices Industry Growth Trends 12 Company Profiles And 2023 Future Market Analysis 2019 to 2023

Embolic Protection Devices Industry Highlights Embolic protection devices are devices used to prevent or reduce plaque debris from reaching the distal bed during surgical procedures. They are commonly used in Saphenous Vein Graft (SVG) interventions and during carotid artery stenting procedures. Other key factors such as advancement in the field of healthcare and adoption of advanced equipment by healthcare institutes also drive the growth of the market. However, factors such as lack of trained medical professionals are expected to curb the growth of the market during the forecast period. Global Embolic Protection Devices Industry: Embolic Protection Devices: Increasing prevalence of rate in cardiovascular disorders is likely to drive the growth of the global market at a CAGR of 8.5% during 2018 to 2023. Industry Segmentation The global Embolic Protection Devices Industry is segmented on the basis of type, material, usage, application, and end-user. On the basis

Smart Insulin Pens Industry Research 2019 By Technological Advancements and Emerging Trends

Smart Insulin Pens Industry Comprehensive Research on Strong Growth Opportunities and Demand Analysis Smart Insulin Pens Industry are medical devices used to inject the insulin in patients’ body. Smart insulin pens are less painful and more effective than other drug delivery devices. Global Smart Insulin Pens Industry Accounted for USD 60 Millio n And Is Expected to Register A 10.4% CAGR During The Forecast Period (2018–2023) Key Players: Some of the key players in the global Smart Insulin Pens Industry are Sanofi-Aventis US LLC., Lilly Novo Nordisk A/S, USA, LLC, Digital Medics Pty Ltd., Companion Medical, Emperra GmbH E-Health Technologies, Biocorp, Diamesco Co., Ltd., Smiths Medical, NIPRO Medical Corporation, and InjexUK Get Sample Research Report at  https://www.marketresearchfuture.com/sample_request/6789 Segmentation: The global Smart Insulin Pens Industry has been segmented on the basis of product type, usability, and distribution channel. The produ

Surgical Robots Industry By Top Manufactures, Business Growth, Future Opportunities, Size and Growth Drivers

Surgical Robots Industry Outlook According to a recent study report published by the Market Research Future analysts, the global Surgical Robots Industry is growing at a moderate pace; Robotic surgery has advantages over traditional open surgeries such as greater precision, miniaturization, less pain, smaller incisions and scars, low blood loss, and quicker healing time. Another benefit is greater articulation due to better manipulation resulting in improved ergonomics. Due to the combined effects of the above mentioned benefits there is a reduced duration of hospital stays. Surgical Robots Industry Competitive Dashboard: Intuitive Surgical Inc., Medtronic plc, Johnson & Johnson, Google Life Sciences, Stryker Corporation, TransEnterix, Mazor Robotics, and Hansen Medical are some of the prominent players at the forefront of competition in the Global Surgical Robots Industry and are profiled in MRFR Analysis. Segmentation: Global Surgical Robots Industry is segme

Ultrasound Devices Industry Development Status, Emerging Technologies & Competitive Landscapes

Ultrasound Devices Industry Driven by Growing Demand for Noninvasive Medical Imaging and Diagnosis Ultrasound devices work by sending out high-frequency sound waves that provide a picture of the targeted area based on the response of various bodily tissues to the sound waves. The global Ultrasound Devices Industry is expected to exhibit a strong 8.1% CAGR over the forecast period, Ultrasound Devices Industry Segmentation: The Global Ultrasound Devices Market is segmented by application into diagnostic and therapeutic. The diagnostic application segment holds a dominant share of 68% in the global Ultrasound Devices Industry and is likely to remain the leading contributor over the forecast period. On the basis of branch of medicine, the Ultrasound Devices Industry is segmented into radiology, OB/GYN, cardiac, and others. By product type, the global Ultrasound Devices Industry is segmented into cart-based and portable. By end user, the global Ultrasound Devices I

Uterine Fibroid Industry Therapeutics, Strategic Assessment, Diagnosis and Focus On Key Drivers

United States Uterine Fibroid Industry Drivers: United States Uterine Fibroid Industry – Overview The United States Uterine Fibroid Industry is showing the significant growth; mainly due to change in lifestyle mainly dietary pattern, growing number of hysterectomy surgeries. Additionally rising in aging population also leads the Uterine Fibroid Industry with in this region. According to U.S. Department of Health and Human Services, study found that before 50s 70% of white and 80% of African Americans are diagnosed with fibroids. Also more than 200,000 hysterectomies are performed each year for uterine fibroids. Hysterectomies is the surgery that is used to remove the uterus, if the condition is painful. AstraZeneca (U.K), Cook Medical Inc. (U.S.), Boston Scientific Corporation (U.S.), GE Healthcare (U.K), AbbVie Inc. (U.S.), Hologic (U.S.), CooperSurgical Inc. (U.S.), C. R. Bard, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and Bayer AG (Germany) are some of the lead

Global Healthcare Mobility Solutions Industry Technological Opportunity by Application, Types and Forecasting till 2023

Healthcare Mobility Solutions Industry Introduction There has been a huge transformation in the health sector as they have been one of the first adopters of advanced mobile technology within their products and services. By quickly recognizing the benefits yielded by the mobile enabled applications, health care providers have overcome most of the challenges faced by them. Healthcare mobility solutions are the new age technological advancements in the field of healthcare. Healthcare mobility solutions enables the medical professional to provide the best possible medical service in less time with the use of various mobile applications and services. Mobility solutions also help in reducing the overall healthcare cost. Healthcare Mobility Solutions Industry  is growing rapidly post 2016 with the CAGR of ~24%, thus growth period of this market can be stated as from 2017-2022.  Healthcare Mobility Solutions Industry Key Players Airstrip Technologies, Inc. (U.S.), At&T, Inc. (

Global Oligonucleotide Synthesis Industry share Analysis and Trends 2019 - 2023

Oligonucleotide Synthesis Industry - Overview Advancing technologies have substantially raised the hope for better treatment in the healthcare sector. One of the chief driving forces is biotechnology which is constantly updating itself and impacting the former sector. Of the many ensuing projects, oligonucleotide synthesis is an evolving technique that forms inexpensive, custom-made oligonucleotides with the desired sequence. Its importance lies in its contribution in DNA or RNA synthesizing and hybridization and in the synthesis of artificial genes. The global Oligonucleotide Synthesis Industry is expecting an astonishing 10.3% CAGR during the forecast period (2014-2022), reveals Market Research Future (MRFR) in a broadly demonstrated report. The report further incorporates factors that are contributing much for the market growth which includes ventures and investments made by big pharmaceutical companies, contract manufacturing organization’s involvement in the market and

Desmoid Tumors Biopsy, Diagnosis and Treatment Scenario by Expert Professionals

“Global Desmoid Tumors Market Is Expected to Grow at a CAGR 4.5% During the Forecast Period Of 2017-2023”. Desmoid Tumors Market Overview Desmoid tumors are the benign fibrous growths which usually develops in the fibrous tissue of the body, commonly in the arms, legs or midsection, and sometimes in the head and neck. According to the U.S National Library of Medicine, Desmoid tumors are very rare as the rate of occurrence is estimated to be 1 to 2 per 500,000 people worldwide. It is also stated that nearly 900 to 1,500 new cases are registered per year in the United States. Tumors associated with familial adenomatous polyposis (FAP) are less common than sporadic desmoid tumors. On the molecular level, desmoid tumor is characterized by one of the two mutations in the gene i.e. mutations in the adenomatous polyposis coli (APC) gene, or in the β-catenin gene, CTNNB1. During diagnostic procedures CTNNB1 mutation is detected, especially, when pathological differential diagnosi

recent Development in Genu recurvatum Market Technology, Global Share and Trends

Genu recurvatum is also known as knee hyperextension or back knee. It is a type of condition that affects the knee joint to bend backward when the person is in standing position. This problem is more common in women than in men and commonly identified in 0.5%-1.0% of patients undergoing Total knee arthroplasty (TKA).   Genu recurvatum can also cause other conditions such as knee pain or knee osteoarthritis. Genu recurvatum can be mild, moderate, or severe. This deformity can also arise from other medical conditions such as, quadriceps weakness, bone deformities, paralysis, plantar foot flexion, and high tibial osteotomies. Genu recurvatum can be congenital or acquired. Congenital genu recurvatum (CGR) is extremely rare condition and found to be associated with other malformations such as talipes equinovarus, hip dysplasia, and absent patella.   High cost of treatment & management genu recurvatum and related disorders, and lack of infrastructure in the middle- and low-inco

Newer Technology in Dupuytren’s contracture Market Treatment and Diagnosis Overview

Dupuytren's contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin. In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren's contracture is typically not painful and generally affects the ring finger followed by the little and middle finger. The exact causes of Dupuytren's contracture are unknown however the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. The market drivers for Dupuytren’s contracture market are, increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytren’s contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc. The  global Dupuytren’s contracture market is expected to reach USD 5.5 billion

Latest Vasectomy Treatment Technology and Upcoming Trends Scenario 2019

The “ Global  Vasectomy Market Size  Is Expected to Reach USD 24.0 Billion at a CAGR of ~ 7.1 % During the By the End of Forecast Period 2017-2023 ”. Vasectomy is male sterilization surgery, which involves severing the male vas deferens to prevent sperm from entering into the urethra. It is a permanent procedure of preventing fertilization as reversal is costly and often does not restore the male's fertility. The advantages of minimal invasive surgical procedures such as low hospital stay, low trauma and surgical footprint, less pain has resulted in greater demand for minimal invasive procedures and thus, greater acceptance. Vasectomy Market Segmental Analysis: The global vasectomy market has been segmented on the basis of type, drug, patient, and end user. Based on the type , the market has been segmented as conventional vasectomy, no-scalpel vasectomy, and minimally invasive vasectomy. Based on the drug , the market has been segmented as anesthetics, pai